Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene s PCR Reagents Infringe Third Wave s Invader Tech; Jury to Deliberate Damages

Click  here for an updated version of this article.

NEW YORK, Sept. 1 (GenomeWeb News) - A jury has determined that Stratagene's quantitative PCR and RT-PCR reagents infringe two patents held by Third Wave Technologies as part of its Invader technology, Stratagene said today.


The jury, appointed by the United States District Court for the Western District of Wisconsin, found that certain embodiments of Stratagene's FullVelocity technology violate Third Weave's US patents Nos. 6,090,543 and 6,348,314. The jury will now hear arguments with respect to damages.


Third Wave filed the suit  last September. At the time, Stratagene said certain embodiments of its FullVelocity technology are not covered by Third Wave's patents.


In May, Stratagene countersued Third Wave claiming that Third Wave infringes patents that cover its FullVelocity technology. Stratagene's patents are USpatent Nos. 6,350,580; 6,528,254; 6,548,250; 6,589,743; and 6,893,819.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.